The backing behind every claim
Seven deep-dives covering the clinical science, the demand pools, the billing architecture, and the compliance posture. Open any article to read the full evidence base behind the claim.
The science
Targeted Pulsed Electromagnetic Field therapy modulates intracellular calcium signaling through the calmodulin pathway, producing a downstream anti-inflammatory and tissue-repair cascade.
Demand pool #1
Post-surgical pain is the primary on-ramp to opioid dependence in the U.
Demand pool #2
Osteoarthritis affects 32.
Demand pool #3
HCPCS code G0329 (electromagnetic therapy for chronic wounds) has been a Medicare benefit since 2004.
The surgeon incentive
Remote Therapeutic Monitoring (CPT 98975 + 98977 + 98980) pays approximately $115.
Compliance architecture
The Anti-Kickback Statute (42 USC 1320a-7b(b)) prohibits remuneration to induce referrals for federally covered items.
The prescription path
FDA Class II devices require a physician's prescription.
The first result
In a double-blind, placebo-controlled RCT published in Plastic & Reconstructive Surgery, patients using the active tPEMF device reported pain scores roughly 57% lower than the sham group at one hour.
The drug-free outcome
In Rhode et al.
Cardiac surgery
Work from Baylor College of Medicine and the DeBakey VA examined tPEMF in coronary artery bypass (CABG) patients and found roughly a 70% reduction in morphine-equivalent dose.
The economic proof
Alongside the 70% morphine reduction, the CABG study found approximately a two-day shorter median hospital length of stay.
The double-blind result
Heden and Pilla (Aesthetic Plastic Surgery, 2008) ran a 42-patient double-blind trial of tPEMF following breast augmentation and found an 87% reduction in post-operative pain (p < 0.
The safety record
No serious adverse events attributable to tPEMF have been documented across millions of treatments and the full published clinical record.
Knee replacement
A 2023 peer-reviewed orthopedic RCT found approximately 50% reduction in post-operative pain in tPEMF-treated patients following total knee arthroplasty.
Osteoarthritis
SofPulse clinical monitoring data show a 60% reduction in OA pain maintained over the observation period.